GB1338541A - Therapeutic compositions containing sulphamethyoxypyridazine or sulphaethoxypyridazine - Google Patents
Therapeutic compositions containing sulphamethyoxypyridazine or sulphaethoxypyridazineInfo
- Publication number
- GB1338541A GB1338541A GB1167472A GB1338541DA GB1338541A GB 1338541 A GB1338541 A GB 1338541A GB 1167472 A GB1167472 A GB 1167472A GB 1338541D A GB1338541D A GB 1338541DA GB 1338541 A GB1338541 A GB 1338541A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- composition
- bismuth
- sulphaethoxypyridazine
- march
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 9
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 239000001856 Ethyl cellulose Substances 0.000 abstract 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 229920001249 ethyl cellulose Polymers 0.000 abstract 3
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 2
- 150000001621 bismuth Chemical class 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 abstract 1
- HWSISDHAHRVNMT-UHFFFAOYSA-N Bismuth subnitrate Chemical compound O[NH+]([O-])O[Bi](O[N+]([O-])=O)O[N+]([O-])=O HWSISDHAHRVNMT-UHFFFAOYSA-N 0.000 abstract 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 abstract 1
- 229940036358 bismuth subcarbonate Drugs 0.000 abstract 1
- 229960001482 bismuth subnitrate Drugs 0.000 abstract 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- VLYWMPOKSSWJAL-UHFFFAOYSA-N sulfamethoxypyridazine Chemical compound N1=NC(OC)=CC=C1NS(=O)(=O)C1=CC=C(N)C=C1 VLYWMPOKSSWJAL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004936 sulfamethoxypyridazine Drugs 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12702471A | 1971-03-22 | 1971-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1338541A true GB1338541A (en) | 1973-11-28 |
Family
ID=22427933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1167472A Expired GB1338541A (en) | 1971-03-22 | 1972-03-13 | Therapeutic compositions containing sulphamethyoxypyridazine or sulphaethoxypyridazine |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3758680A (enExample) |
| JP (1) | JPS5713522B2 (enExample) |
| AU (1) | AU462695B2 (enExample) |
| CA (1) | CA983391A (enExample) |
| DE (1) | DE2213957A1 (enExample) |
| ES (1) | ES401083A1 (enExample) |
| FR (1) | FR2130559B1 (enExample) |
| GB (1) | GB1338541A (enExample) |
| IT (1) | IT1043890B (enExample) |
| ZA (1) | ZA718319B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| CN109568282A (zh) * | 2018-12-28 | 2019-04-05 | 河北威远动物药业有限公司 | 一种含乙酰氨基阿维菌素的瘤胃缓释片剂及制备方法 |
-
1971
- 1971-03-22 US US00127024A patent/US3758680A/en not_active Expired - Lifetime
- 1971-12-10 CA CA129,902A patent/CA983391A/en not_active Expired
- 1971-12-13 ZA ZA718319A patent/ZA718319B/xx unknown
- 1971-12-15 AU AU36890/71A patent/AU462695B2/en not_active Expired
-
1972
- 1972-02-29 IT IT48661/72A patent/IT1043890B/it active
- 1972-03-13 GB GB1167472A patent/GB1338541A/en not_active Expired
- 1972-03-22 FR FR7210061A patent/FR2130559B1/fr not_active Expired
- 1972-03-22 DE DE19722213957 patent/DE2213957A1/de active Pending
- 1972-03-22 ES ES401083A patent/ES401083A1/es not_active Expired
- 1972-03-22 JP JP2888972A patent/JPS5713522B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT1043890B (it) | 1980-02-29 |
| ZA718319B (en) | 1972-09-27 |
| JPS4852913A (enExample) | 1973-07-25 |
| AU3689071A (en) | 1973-06-21 |
| FR2130559A1 (enExample) | 1972-11-03 |
| ES401083A1 (es) | 1975-10-01 |
| CA983391A (en) | 1976-02-10 |
| FR2130559B1 (enExample) | 1975-06-20 |
| JPS5713522B2 (enExample) | 1982-03-17 |
| US3758680A (en) | 1973-09-11 |
| DE2213957A1 (de) | 1972-09-28 |
| AU462695B2 (en) | 1975-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1405088A (en) | Slow release formulation | |
| GB1517480A (en) | Opiate analgesic formulation with a low potential for abuse | |
| GB1359614A (en) | Method for the manufacture of effervescent tablets | |
| GB1374823A (en) | Triazolylbenzophenones | |
| GB1157186A (en) | Serum Lipid Lowering Pyridine Derivatives | |
| US4954349A (en) | Oral magnesium and potassium compositions and use | |
| GB1279214A (en) | Long-acting oral carrier | |
| GB1141994A (en) | Powder-containing preparations for application to the human skin | |
| AU619481B2 (en) | Oral magnesium and potassium compositions and use | |
| GB1338541A (en) | Therapeutic compositions containing sulphamethyoxypyridazine or sulphaethoxypyridazine | |
| GB1422193A (en) | Pharmaceutical compositions | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| US3066075A (en) | Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1362845A (en) | Benzyl alcohol derivatives | |
| ES404959A1 (es) | Un procedimiento para preparar una composicion acuosa es- table de dexiciclina. | |
| IL45565A0 (en) | Carbonic acid derivatives of 2-mercapto-4,5-dichloro-thiazole,their preparation and their use as herbicides | |
| GB1153324A (en) | Sustained Release Tablets | |
| GB1388856A (en) | Fibrinolytic activators comprising derivatives of phenyl benzoate | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| IE34648L (en) | Pharmaceutical composition containing garcinia acid | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| GB791644A (en) | Barbiturate pharmaceutical preparations | |
| GB1125924A (en) | Organic bismuth derivative | |
| GB1509778A (en) | Pharmaceutical composition and dosage units thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |